Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marion Chevandier"'
Autor:
Charlotte Primard, Elodie Monchâtre-Leroy, Judith Del Campo, Séverine Valsesia, Elsa Nikly, Marion Chevandier, Franck Boué, Alexandre Servat, Marine Wasniewski, Evelyne Picard-Meyer, Thomas Courant, Nicolas Collin, Francisco J. Salguero, Alexandre Le Vert, Delphine Guyon-Gellin, Florence Nicolas
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Spike-based COVID-19 vaccines induce potent neutralizing antibodies but their efficacy against SARS-CoV-2 variants decreases. OVX033 is a recombinant protein composed of the full-length nucleocapsid (N) protein of SARS-CoV-2 genetically fused to olig
Externí odkaz:
https://doaj.org/article/365960a0e1264a18b085bf270d352fda
Autor:
Judith Del Campo, Julien Bouley, Marion Chevandier, Carine Rousset, Marjorie Haller, Alice Indalecio, Delphine Guyon-Gellin, Alexandre Le Vert, Fergal Hill, Sophia Djebali, Yann Leverrier, Jacqueline Marvel, Béhazine Combadière, Florence Nicolas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Tissue-resident memory (TRM) CD8+ T-cells play a crucial role in the protection against influenza infection but remain difficult to elicit using recombinant protein vaccines. OVX836 is a recombinant protein vaccine, obtained by the fusion of the DNA
Externí odkaz:
https://doaj.org/article/a29998bf5ac04861bd013b4bdbfe9fcd
Autor:
Florence Nicolas, Marion Chevandier, Ilse De Coster, Pierre Van Damme, Manon Lambiel, Simonetta Viviani, Paul Willems, Kanchanamala Withanage, Nathalie Cools, Alexandre Le Vert, Jessika Tourneur
Publikováno v:
The journal of infectious diseases
Background OVX836 is a recombinant protein vaccine targeting the highly conserved influenza nucleoprotein (NP), which could confer broad-spectrum protection against this disease. Methods A randomized, placebo-controlled, double-blind, dose-escalating
Autor:
Sophia Djebali, Florence Nicolas, Alexandre Le Vert, Judith del Campo, Carine Rousset, Béhazine Combadière, Jacqueline Marvel, Fergal Hill, Julien Bouley, Yann Leverrier, Marion Chevandier, Delphine Guyon-Gellin, Alice Indalecio, Marjorie Haller
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, 2021, 12, ⟨10.3389/fimmu.2021.678483⟩
Frontiers in Immunology, Frontiers, 2021, 12, ⟨10.3389/fimmu.2021.678483⟩
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, 2021, 12, ⟨10.3389/fimmu.2021.678483⟩
Frontiers in Immunology, Frontiers, 2021, 12, ⟨10.3389/fimmu.2021.678483⟩
Frontiers in Immunology, Vol 12 (2021)
International audience; Tissue-resident memory (TRM) CD8+ T-cells play a crucial role in the protection against influenza infection but remain difficult to elicit using recombinant protein vaccines. OVX836 is a recombinant protein vaccine, obtained b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8dde223f1ff7dab9339c7406bf551b0
https://hal.sorbonne-universite.fr/hal-03278552
https://hal.sorbonne-universite.fr/hal-03278552